Search Results for: fat

Janet Rossant, ISSCR President, on her goals, cloning, non-compliant clinics, iPS cells, and future of field

New ISSCR President, Dr. Janet Rossant, kindly agreed to do an interview with me focused on the future of ISSCR, her plans for her tenure, and some key issues in the field. Dr. Rossant is Chief of Research at The Hospital for Sick Children in Toronto. 1. The stem cell arena is a very rapidly changing one […]

Janet Rossant, ISSCR President, on her goals, cloning, non-compliant clinics, iPS cells, and future of field Read More »

Delightful overview of ISSCR 2013 by guest blogger Dr. Susan Lim

By Dr. Susan Lim A record 4100 delegates attended the 11th Annual Meeting of the International Society for Stem Cell Research (ISSCR), held at the Convention and Exhibition Center in Boston from 12-15 June 2013. Co-sponsored by the Harvard Stem Cell Institute, the Meeting featured 7 Plenary sessions including a Presidential Symposium, 20 concurrent scientific

Delightful overview of ISSCR 2013 by guest blogger Dr. Susan Lim Read More »

ACT patent filing for MSCs: of Dancing Mice & Multiple Sclerosis

dancing-mice

Is Advanced Cell Technology (ACT) on the road to cure Multiple Sclerosis (MS) using stem cells and specifically MSCs? Some folks seem to think it’s quite possible, but I remain skeptical. Still there have been some interesting developments. ACT has a relatively new patent filing for a mesenchymal stromal cell (MSC) product that was just

ACT patent filing for MSCs: of Dancing Mice & Multiple Sclerosis Read More »

My response to ‘Our Bodies, Our Cells’ Harvard post on deregulation

Mary-Ann-Chirba

Over at the Harvard Law “Bill of Health” blog, Mary Ann Chirba and Alice A. Nobel posted a piece entitled “Our Bodies, Our Cells” a few days ago that has generated a lot of discussion about FDA regulation of stem cell interventions. Their piece really has two parts. In the first part they go through

My response to ‘Our Bodies, Our Cells’ Harvard post on deregulation Read More »

Jury is still out on purported adult pluripotent stem cells despite new MUSE paper

MUSE-cells

Are MUSE cells for real? Stem cells come in different types that vary in a key property called “potency”, but very few are pluripotent. The more potency, the greater the flexibility of a stem cell to make other cell types. Flexibility in the cellular world is power. The most powerful stem cells generally used are

Jury is still out on purported adult pluripotent stem cells despite new MUSE paper Read More »

Leigh Turner Reports Company Precision StemCell To FDA citing numerous concerns including treatment of a minor

What is up with the stem cell company, Precision StemCell, these days? I can’t imagine they are exactly celebrating after having been reported to the FDA. They also have apparently moved operations from the US to Colombia at some point recently. What’s the deal here? First, a little background is helpful. In 2012, University of

Leigh Turner Reports Company Precision StemCell To FDA citing numerous concerns including treatment of a minor Read More »

Dr. Steven Victor of Intellicell Comments on its Stem Cell Treatments

Steven-Victor-250x3001

Dr. Steven Victor, CEO of Intellicell, seems to have made two comments on a recent blog post I did on stem cell sports medicine (see below). Victor and Intellicell received a warning letter from the FDA in March 2012 with the FDA. I’m not aware of Intellicell publicly addressing the FDA issues. If you have, Intellicell, please

Dr. Steven Victor of Intellicell Comments on its Stem Cell Treatments Read More »

More on Betatrophin, my take on the Cell paper, and a video

Melton-Peng-Yi-300x1861

I finally got a chance to read the Cell paper by the Melton team on Betatrophin and it is quite cool. Update — Unfortunately the Betatrophin paper discussed here originally back in 2013 has now largely been proven to have come to incorrect conclusions (for more read this). I think one big question is whether

More on Betatrophin, my take on the Cell paper, and a video Read More »